• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氨基糖苷类药物药代动力学与与器官功能障碍相关的生物学参数的关系:腹腔感染危重症患者的病例系列研究。

Relationship between amikacin pharmacokinetics and biological parameters associated with organ dysfunction: a case series study of critically ill patients with intra-abdominal sepsis.

机构信息

Department of Clinical Pharmacy, Tehran University of Medical Sciences, Tehran, The Islamic Republic of Iran.

School of Clinical Sciences, Faculty of Health, Queensland University of Technology, Brisbane, Queensland, Australia.

出版信息

Eur J Hosp Pharm. 2022 Mar;29(e1):e72-e76. doi: 10.1136/ejhpharm-2021-003089. Epub 2021 Nov 11.

DOI:10.1136/ejhpharm-2021-003089
PMID:34764144
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8899638/
Abstract

OBJECTIVES

This study aimed to evaluate the relationship between amikacin pharmacokinetics and the biomarkers associated with organ dysfunction in critically ill patients with intra-abdominal sepsis.

METHODS

A case series involving critically ill patients with intra-abdominal sepsis who received an amikacin loading dose of 20-25 mg/kg intravenous infusion was studied. The 1-, 2-, 4-, 6- and 24-hour amikacin serum concentrations were measured to calculate the pharmacokinetic parameters. The Sequential Organ Failure Assessment (SOFA) score, white blood cells, neutrophil to lymphocyte ratio, platelet count, serum creatinine, creatinine clearance, bilirubin, partial pressure of oxygen to fraction of inspired oxygen ratio, serum albumin, procalcitonin, lactate level, erythrocyte sedimentation rate (ESR) and C-reactive protein were recorded. A linear regression analysis was performed to examine the relationship between the amikacin pharmacokinetics and the biological parameters.

RESULTS

Twenty-one patients were studied. A significant correlation was found between the volume of distribution and ESR (p<0.05, r=0.844). Moreover, drug clearance had a significant inverse correlation with serum lactate (p<0.05, r=-0.603). No other significant correlations were found.

CONCLUSIONS

ESR and serum lactate were identified as useful predictors of amikacin pharmacokinetics in critically ill patients with intra-abdominal sepsis and may help guide the selection of appropriate empirical dosing.

摘要

目的

本研究旨在评估氨基糖苷类药物药代动力学与腹腔感染危重症患者器官功能障碍相关生物标志物之间的关系。

方法

本病例系列研究纳入了接受氨基糖苷类药物负荷剂量 20-25mg/kg 静脉输注的腹腔感染危重症患者。测定 1、2、4、6 和 24 小时的氨基糖苷类药物血清浓度,以计算药代动力学参数。记录序贯器官衰竭评估(SOFA)评分、白细胞计数、中性粒细胞与淋巴细胞比值、血小板计数、血清肌酐、肌酐清除率、胆红素、氧分压与吸入氧分数比值、血清白蛋白、降钙素原、乳酸水平、红细胞沉降率(ESR)和 C 反应蛋白。采用线性回归分析评估氨基糖苷类药物药代动力学与生物学参数之间的关系。

结果

共纳入 21 例患者。分布容积与 ESR 之间存在显著相关性(p<0.05,r=0.844)。此外,清除率与血清乳酸呈显著负相关(p<0.05,r=-0.603)。未发现其他有意义的相关性。

结论

ESR 和血清乳酸可作为腹腔感染危重症患者氨基糖苷类药物药代动力学的有用预测指标,可能有助于指导经验性用药剂量的选择。

相似文献

1
Relationship between amikacin pharmacokinetics and biological parameters associated with organ dysfunction: a case series study of critically ill patients with intra-abdominal sepsis.氨基糖苷类药物药代动力学与与器官功能障碍相关的生物学参数的关系:腹腔感染危重症患者的病例系列研究。
Eur J Hosp Pharm. 2022 Mar;29(e1):e72-e76. doi: 10.1136/ejhpharm-2021-003089. Epub 2021 Nov 11.
2
Population Pharmacokinetic Study of the Suitability of Standard Dosing Regimens of Amikacin in Critically Ill Patients with Open-Abdomen and Negative-Pressure Wound Therapy.一项关于开腹合并负压伤口治疗的危重症患者中应用标准剂量阿米卡星的适用性的群体药代动力学研究。
Antimicrob Agents Chemother. 2020 Mar 24;64(4). doi: 10.1128/AAC.02098-19.
3
Relationship between hemodynamic and vital support measures and pharmacokinetic variability of amikacin in critically ill patients with sepsis.脓毒症重症患者中血流动力学和生命支持措施与阿米卡星药代动力学变异性之间的关系。
Crit Care Med. 1997 May;25(5):806-11. doi: 10.1097/00003246-199705000-00016.
4
Influence of sepsis on higher daily dose of amikacin pharmacokinetics in critically ill patients.脓毒症对危重症患者更高日剂量阿米卡星药代动力学的影响。
Eur Rev Med Pharmacol Sci. 2013 Feb;17(3):285-91.
5
Evaluation of Amikacin Pharmacokinetics in Critically Ill Patients with Intra-abdominal Sepsis.腹腔内脓毒症重症患者阿米卡星药代动力学评估
Adv Pharm Bull. 2020 Jan;10(1):114-118. doi: 10.15171/apb.2020.014. Epub 2019 Dec 11.
6
Evaluation of amikacin dosing schedule in critically ill elderly patients with different stages of renal dysfunction.评价不同肾功能阶段危重症老年患者阿米卡星的给药方案。
Eur J Hosp Pharm. 2022 Mar;29(e1):e67-e71. doi: 10.1136/ejhpharm-2021-002986. Epub 2021 Sep 29.
7
An open prospective study of amikacin pharmacokinetics in critically ill patients during treatment with continuous venovenous haemodiafiltration.一项关于氨基糖苷类抗生素阿米卡星在连续性静脉-静脉血液透析滤过治疗危重症患者时的药代动力学的开放性前瞻性研究。
BMC Pharmacol Toxicol. 2012 Nov 8;13:14. doi: 10.1186/2050-6511-13-14.
8
Amikacin population pharmacokinetics among paediatric burn patients.儿科烧伤患者中阿米卡星的群体药代动力学。
Burns. 2014 Mar;40(2):311-8. doi: 10.1016/j.burns.2013.06.015. Epub 2013 Jul 19.
9
Quantification and Explanation of the Variability of First-Dose Amikacin Concentrations in Critically Ill Patients Admitted to the Emergency Department: A Population Pharmacokinetic Analysis.急诊收治的危重症患者首剂阿米卡星浓度变异性的定量和解释:一项群体药代动力学分析。
Eur J Drug Metab Pharmacokinet. 2021 Sep;46(5):653-663. doi: 10.1007/s13318-021-00698-w. Epub 2021 Jul 23.
10
Population pharmacokinetic modeling and optimal sampling strategy for Bayesian estimation of amikacin exposure in critically ill septic patients.群体药代动力学模型和最佳采样策略在重症脓毒症患者中贝叶斯估算阿米卡星暴露的应用。
Ther Drug Monit. 2010 Dec;32(6):749-56. doi: 10.1097/FTD.0b013e3181f675c2.

引用本文的文献

1
Pharmacokinetic variability and significance of therapeutic drug monitoring for broad-spectrum antimicrobials in critically ill patients.危重症患者中广谱抗菌药物的药代动力学变异性及治疗药物监测的意义
J Pharm Health Care Sci. 2025 Mar 17;11(1):21. doi: 10.1186/s40780-025-00425-6.
2
The relation between inflammatory biomarkers and drug pharmacokinetics in the critically ill patients: a scoping review.危重症患者炎症生物标志物与药物药代动力学的关系:范围综述。
Crit Care. 2024 Nov 19;28(1):376. doi: 10.1186/s13054-024-05150-4.

本文引用的文献

1
Can Intra-abdominal Pressure Predict the Pharmacokinetics of Aminoglycosides in Critically Ill Patients With Intra-abdominal Sepsis?腹内压能否预测腹腔内感染重症患者氨基糖苷类药物的药代动力学?
Am J Ther. 2022;29(3):e376-e378. doi: 10.1097/MJT.0000000000001404. Epub 2021 Jun 11.
2
Evaluation of amikacin dosing schedule in critically ill elderly patients with different stages of renal dysfunction.评价不同肾功能阶段危重症老年患者阿米卡星的给药方案。
Eur J Hosp Pharm. 2022 Mar;29(e1):e67-e71. doi: 10.1136/ejhpharm-2021-002986. Epub 2021 Sep 29.
3
Detection of subclinical nephrotoxicity induced by aminoglycosides in critically ill elderly patients using trough levels and urinary neutrophil gelatinase-associated lipocalin.使用氨基糖苷类药物的谷浓度和尿中性粒细胞明胶酶相关脂质运载蛋白检测危重症老年患者亚临床肾毒性。
Eur J Hosp Pharm. 2022 Mar;29(e1):e63-e66. doi: 10.1136/ejhpharm-2021-002868. Epub 2021 Jul 20.
4
Antibiotic therapy in sepsis: No next time for a second chance!脓毒症中的抗生素治疗:没有下次机会!
J Clin Pharm Ther. 2021 Aug;46(4):872-876. doi: 10.1111/jcpt.13403. Epub 2021 Mar 12.
5
An Update on Sepsis Biomarkers.脓毒症生物标志物的最新进展
Infect Chemother. 2020 Mar;52(1):1-18. doi: 10.3947/ic.2020.52.1.1.
6
Evaluation of Amikacin Pharmacokinetics in Critically Ill Patients with Intra-abdominal Sepsis.腹腔内脓毒症重症患者阿米卡星药代动力学评估
Adv Pharm Bull. 2020 Jan;10(1):114-118. doi: 10.15171/apb.2020.014. Epub 2019 Dec 11.
7
Septic acute kidney injury patients in emergency department: The risk factors and its correlation to serum lactate.急诊科脓毒症急性肾损伤患者:危险因素及其与血清乳酸的相关性。
Am J Emerg Med. 2019 Feb;37(2):204-208. doi: 10.1016/j.ajem.2018.05.012. Epub 2018 May 16.
8
Evaluation of Epithelial Lining Fluid Concentration of Amikacin in Critically Ill Patients With Ventilator-Associated Pneumonia.评价机械通气相关性肺炎危重症患者肺泡灌洗液中阿米卡星浓度。
J Intensive Care Med. 2020 Apr;35(4):400-404. doi: 10.1177/0885066618754784. Epub 2018 Feb 22.
9
Obesity, acute kidney injury and mortality in patients with sepsis: a cohort analysis.肥胖、急性肾损伤与脓毒症患者的死亡率:一项队列分析。
Ren Fail. 2018 Nov;40(1):120-126. doi: 10.1080/0886022X.2018.1430588.
10
Multiple Organ Dysfunction: The Defining Syndrome of Sepsis.多器官功能障碍:脓毒症的决定性综合征。
Surg Infect (Larchmt). 2018 Feb/Mar;19(2):184-190. doi: 10.1089/sur.2017.298. Epub 2018 Jan 23.